Centene is planning to sell its Operose clinics in the U.K., its last remaining business in the country, the Financial Times reported Aug. 30.
The Latest
Wegovy, Novo Nordisk's expensive weight loss drug, could reduce the risk of cardiovascular events — but at a steep cost to insurers, Bloomberg reported Aug. 31.
Health plans have historically struggled to deliver personalization that increases member engagement, improves care coordination, drives better outcomes and reduces costs. That’s despite spending 10% or more of their administrative budget on care management, according to McKinsey & Company, which…
CMS is urging states to correct an issue that could result in eligible people being removed from Medicaid.
More than 5 million people have been disenrolled during the Medicaid redeterminations process. In some states, Medicaid recipients have filed legal challenges to the process, and whistleblowers are raising alarms.
Highmark Health Plans has named Ja'Ron Bridges senior vice president and CFO, effective Sept. 25.
Inland Empire Health Plan has named Supriya Sood as chief people officer.
Wellcare, Centene's Medicare Advantage business, is partnering with the American Legion on Medicare Advantage plans designed to complement benefits veterans receive through the VA.
UnitedHealthcare is cutting 20 percent of its prior authorizations in two waves. The first cuts take effect Sept. 1 and the second phase goes into effect Nov. 1.
CenterWell, Humana's older-adult focused primary care business, is expanding to in-home primary care.